Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | IAPP | P10997 | 4/20 | 0.40 |
| ▸ | PRKCI | P41743 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 2/20 | 0.36 |
| ▸ | CTSG | P08311 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3258418 | 0.89 | GABRA1 (0.55) | GABRA1GABRB2IAPP | |
| SCHEMBL3187499 | 0.88 | USP2 (0.37) | GABRA1GABRB2IAPPPRKCIPPARG | |
| SCHEMBL3261977 | 0.82 | ALDH1A1 (0.39) | GABRA1GABRB2 | |
| SCHEMBL3260982 | 0.81 | GABRA1 (0.57) | GABRA1GABRB2ELANECTSG | |
| SCHEMBL3178976 | 0.81 | ALOX5 (0.39) | IAPPALOX5PTGS2PPARGPPARA | |
| SCHEMBL3259308 | 0.78 | CA2 (0.44) | GABRA1GABRB2IAPPALOX5PTGS2 | |
| SCHEMBL3261080 | 0.78 | GABRA1 (0.44) | GABRA1GABRB2 | |
| SCHEMBL3259025 | 0.78 | PTPN1 (0.39) | ELANECTSG | |
| SCHEMBL3180640 | 0.78 | GABRA1 (0.45) | GABRA1GABRB2 | |
| SCHEMBL674691 | 0.75 | GABRA1 (0.64) | GABRA1GABRB2IAPPPRKCIALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8952189-B2 | Process for preparing diaryl carbonates or alkyl aryl carbonates from dialkyl carbonates | BAYER MATERIALSCIENCE AG (DE) | 2015-02-10 | — | — | US | disclosed |
| US-20100261928-A1 | PROCESS FOR PREPARING DIARYL CARBONATES OR ALKYL ARYL CARBONATES FROM DIALKYL CARBONATES | BAYER MATERIALSCIENCE AG (DE) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261928-A1 | PROCESS FOR PREPARING DIARYL CARBONATES OR ALKYL ARYL CARBONATES FROM DIALKYL CARBONATES | HDHD5, AHR, AGL | GABRA1 3932/4885GABRB2 4443/4885IAPP 2310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.